Annual Retained Earnings
-$388.05 M
-$69.44 M-21.80%
31 December 2023
Summary:
Silence Therapeutics annual retained earnings is currently -$388.05 million, with the most recent change of -$69.44 million (-21.80%) on 31 December 2023. During the last 3 years, it has fallen by -$136.99 million (-54.57%). SLN annual retained earnings is now -28523.24% below its all-time high of -$1.36 million, reached on 31 December 1995.SLN Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$463.89 M
-$58.96 M-14.56%
01 September 2024
Summary:
Silence Therapeutics quarterly retained earnings is currently -$463.89 million, with the most recent change of -$58.96 million (-14.56%) on 01 September 2024. Over the past year, it has dropped by -$109.32 million (-30.83%). SLN quarterly retained earnings is now -1869.01% below its all-time high of -$23.56 million, reached on 30 June 2003.SLN Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLN Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.8% | -30.8% |
| 3 y3 years | -54.6% | -61.8% |
| 5 y5 years | -128.6% | -132.8% |
SLN Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -54.6% | at low | -66.4% | at low |
| 5 y | 5 years | -128.6% | at low | -132.8% | at low |
| alltime | all time | <-9999.0% | at low | -1869.0% | at low |
Silence Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$463.89 M(+14.6%) |
| June 2024 | - | -$404.93 M(+4.9%) |
| Mar 2024 | - | -$385.95 M(-0.5%) |
| Dec 2023 | -$388.05 M(+21.8%) | -$388.05 M(+9.4%) |
| Sept 2023 | - | -$354.57 M(-0.6%) |
| June 2023 | - | -$356.65 M(+5.7%) |
| Mar 2023 | - | -$337.38 M(+5.9%) |
| Dec 2022 | -$318.60 M(+5.9%) | -$318.60 M(+14.3%) |
| Sept 2022 | - | -$278.78 M(-5.2%) |
| June 2022 | - | -$294.19 M(-2.9%) |
| Mar 2022 | - | -$302.98 M(+0.7%) |
| Dec 2021 | -$300.92 M(+19.9%) | -$300.92 M(+4.9%) |
| Sept 2021 | - | -$286.73 M(+1.7%) |
| June 2021 | - | -$281.90 M(+12.3%) |
| Dec 2020 | -$251.05 M(+26.0%) | -$251.05 M(+25.2%) |
| June 2020 | - | -$200.53 M(+0.6%) |
| Dec 2019 | -$199.30 M(+17.4%) | - |
| Dec 2019 | - | -$199.30 M(+11.3%) |
| June 2019 | - | -$179.08 M(+5.5%) |
| Dec 2018 | -$169.75 M(+7.9%) | - |
| Dec 2018 | - | -$169.75 M(+3.8%) |
| June 2018 | - | -$163.55 M(+3.9%) |
| Dec 2017 | -$157.34 M(+10.5%) | - |
| Dec 2017 | - | -$157.34 M(-0.9%) |
| June 2017 | - | -$158.77 M(+11.5%) |
| Dec 2016 | -$142.45 M(-12.1%) | - |
| Dec 2016 | - | -$142.45 M(-6.5%) |
| June 2016 | - | -$152.34 M(-6.0%) |
| Dec 2015 | -$162.13 M(+1.2%) | - |
| Dec 2015 | - | -$162.13 M(-3.7%) |
| June 2015 | - | -$168.41 M(+5.1%) |
| Dec 2014 | -$160.25 M(+5.8%) | - |
| Dec 2014 | - | -$160.25 M(-3.5%) |
| June 2014 | - | -$166.05 M(+9.6%) |
| Dec 2013 | -$151.49 M(+13.0%) | - |
| Dec 2013 | - | -$151.49 M(+15.1%) |
| June 2013 | - | -$131.63 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | -$134.01 M(+50.5%) | - |
| Dec 2012 | - | -$134.01 M(+6.6%) |
| June 2012 | - | -$125.72 M(+41.2%) |
| Dec 2011 | -$89.02 M(+7.1%) | - |
| Dec 2011 | - | -$89.02 M(-3.3%) |
| June 2011 | - | -$92.03 M(+10.8%) |
| Dec 2010 | -$83.08 M(+13.8%) | - |
| Dec 2010 | - | -$83.08 M(+6.5%) |
| June 2010 | - | -$78.00 M(+6.8%) |
| Dec 2009 | -$73.01 M(+31.0%) | - |
| Dec 2009 | - | -$73.01 M(+6.5%) |
| June 2009 | - | -$68.54 M(+23.0%) |
| Dec 2008 | -$55.74 M(-8.4%) | - |
| Dec 2008 | - | -$55.74 M(-21.3%) |
| June 2008 | - | -$70.79 M(+16.4%) |
| Dec 2007 | -$60.82 M(+21.4%) | - |
| Dec 2007 | - | -$60.82 M(+4.9%) |
| June 2007 | - | -$58.01 M(+15.7%) |
| Dec 2006 | -$50.11 M(+33.9%) | - |
| Dec 2006 | - | -$50.11 M(+17.2%) |
| June 2006 | - | -$42.75 M(+14.2%) |
| Dec 2005 | -$37.43 M(+7.3%) | - |
| Dec 2005 | - | -$37.43 M(+10.6%) |
| June 2005 | - | -$33.83 M(-3.0%) |
| Dec 2004 | -$34.89 M(+28.2%) | - |
| Dec 2004 | - | -$34.89 M(+12.7%) |
| June 2004 | - | -$30.97 M(+13.8%) |
| Dec 2003 | -$27.21 M(+30.4%) | - |
| Dec 2003 | - | -$27.21 M(+15.5%) |
| June 2003 | - | -$23.56 M |
| Dec 2002 | -$20.86 M(+25.7%) | - |
| Dec 2001 | -$16.59 M(+20.1%) | - |
| Dec 2000 | -$13.81 M(+16.8%) | - |
| Dec 1999 | -$11.83 M(+38.1%) | - |
| Dec 1998 | -$8.57 M(+43.7%) | - |
| Dec 1997 | -$5.96 M(+90.8%) | - |
| Dec 1996 | -$3.13 M(+130.5%) | - |
| Dec 1995 | -$1.36 M | - |
FAQ
- What is Silence Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Silence Therapeutics?
- What is Silence Therapeutics annual retained earnings year-on-year change?
- What is Silence Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Silence Therapeutics?
- What is Silence Therapeutics quarterly retained earnings year-on-year change?
What is Silence Therapeutics annual retained earnings?
The current annual retained earnings of SLN is -$388.05 M
What is the all time high annual retained earnings for Silence Therapeutics?
Silence Therapeutics all-time high annual retained earnings is -$1.36 M
What is Silence Therapeutics annual retained earnings year-on-year change?
Over the past year, SLN annual retained earnings has changed by -$69.44 M (-21.80%)
What is Silence Therapeutics quarterly retained earnings?
The current quarterly retained earnings of SLN is -$463.89 M
What is the all time high quarterly retained earnings for Silence Therapeutics?
Silence Therapeutics all-time high quarterly retained earnings is -$23.56 M
What is Silence Therapeutics quarterly retained earnings year-on-year change?
Over the past year, SLN quarterly retained earnings has changed by -$109.32 M (-30.83%)